Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Diabetes Reports

• Publication date

  2018-08-18

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s11892-018-1065-6PMID 30121746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Glucose Sensing Technology And Hypoglycaemia In Type

  2020cited by this paper
• Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.

  2018cited by this paper
• Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial

  2018cited by this paper
• Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes

  2018cited by this paper
• Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes

  2018cited by this paper
• Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol

  2018cited by this paper
• Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations

  2017cited by this paper
• Use of the predictive low glucose management (PLGM) algorithm in Italian adolescents with type 1 diabetes: CareLink™ data download in a real-world setting

  2017cited by this paper
• Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

  2017cited by this paper
• Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes

  2017cited by this paper
• Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

  2017cited by this paper
• Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial

  2017cited by this paper
• 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018

  2017cited by this paper
• Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)

  2017cited by this paper
• Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment

  2017cited by this paper
• Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials

  2017cited by this paper
• Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

  2017cited by this paper
• “Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients

  2017cited by this paper
• Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

  2017cited by this paper
• Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

  2016cited by this paper
• Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump

  2016cited by this paper
• Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes

  2016cited by this paper
• Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2016cited by this paper
• Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System

  2016cited by this paper
• Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.

  2016cited by this paper
• Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

  2016cited by this paper
• Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.

  2016cited by this paper
• IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial

  2016cited by this paper
• Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

  2016cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis

  2016cited by this paper
• High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.

  2015cited by this paper
• Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

  2015cited by this paper
• Hypoglycemia in Type 2 Diabetes - More Common Than You Think

  2015cited by this paper
• Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study

  2015cited by this paper
• Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome)

  2015cited by this paper
• New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

  2015cited by this paper
• Glucose Control in Diabetes: Targets and Therapy

  2015cited by this paper
• The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During Exercise

  2014cited by this paper
• Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 × 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS)

  2014cited by this paper
• A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes

  2014cited by this paper
• Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration

  2014cited by this paper
• Incidence and Correlates of Hypoglycemia in Type 2 Diabetes. The Hypos-1 Study

  2014cited by this paper
• Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus

  2014cited by this paper
• A Psychoeducational Program to Restore Hypoglycemia Awareness: The DAFNE-HART Pilot Study

  2014cited by this paper
• Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

  2014cited by this paper
• Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

  2013cited by this paper
• Mechanisms of hypoglycemia-associated autonomic failure in diabetes.

  2013cited by this paper
• Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

  2013cited by this paper
• Threshold-based insulin-pump interruption for reduction of hypoglycemia.

  2013cited by this paper
• Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.

  2013cited by this paper
• Improved Biomedical and Psychological Outcomes 1 Year After Structured Education in Flexible Insulin Therapy for People With Type 1 Diabetes

  2012cited by this paper
• Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia

  2012cited by this paper
• Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.

  2012cited by this paper
• Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

  2012cited by this paper
• Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes

  2012cited by this paper
• The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study

  2012cited by this paper
• Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes

  2011cited by this paper
• Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

  2011cited by this paper
• Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia

  2011cited by this paper
• Correlates of Quality of Life in Older Adults With Diabetes

  2011cited by this paper
• Hypoglycemia, Diabetes, and Cardiovascular Events

  2010cited by this paper
• Sustained Efficacy of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Subjects with Recurrent Non-Severe and Severe Hypoglycemia and Hypoglycemia Unawareness: A Pilot Study

  2010cited by this paper
• Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2010cited by this paper
• Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

  2009cited by this paper
• Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes

  2008cited by this paper
• Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes

  2008cited by this paper
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

  2007cited by this paper
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

  2005cited by this paper
• Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management

  2005cited by this paper
• Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

  2004cited by this paper
• Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness

  2003cited by this paper
• Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

  2002cited by this paper
• Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

  2000cited by this paper
• Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)

  1998cited by this paper
• Long-Term Intensive Therapy of IDDM Patients With Clinically Overt Autonomic Neuropathy: Effects on Hypoglycemia Awareness and Counterregulation

  1997cited by this paper
• A Multicenter Evaluation of Blood Glucose Awareness Training-II

  1995cited by this paper
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

  1995cited by this paper
• Long-Term Follow-Up Evaluation of Blood Glucose Awareness Training

  1994cited by this paper
• Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

  1993cited by this paper
• Hypoglycemia unawareness.

  1991cited by this paper
• Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

  1991cited by this paper
• Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.

  1984cited by this paper
• Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

  1983cited by this paper
• INSULIN HYPOGLYCÆMIA CHANGES IN NERVOUS MANIFESTATIONS

  1941cited by this paper

• Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States

  2025cites this paper
• CGM-Based Glycemic Metrics Support Estimating Nutritional Risk After Total Pancreatectomy: An Exploratory Retrospective Study

  2025cites this paper
• Interpretable and multimodal fusion methodology to predict severe hypoglycemia in adults with type 1 diabetes

  2025cites this paper
• Case Report: Hybrid closed-loop insulin pump can significantly improve awareness of hypoglycemia

  2025cites this paper
• Automated insulin delivery systems in elderly patients with brittle type 2 diabetes.

  2024cites this paper
• Pilot analysis of insulin pump (CSII) utilization for the treatment of seniors with diabetes in the Czech Republic

  2024cites this paper
• Hypoglycemia Unawareness and Recurrent Severe Hypoglycemia in an Individual With Type 1 Diabetes Mellitus on Insulin

  2024influential citation
• Continuous Glucose Monitoring Profiles and Health Outcomes after Dapagliflozin Plus Saxagliptin vs Insulin Glargine.

  2024cites this paper
• Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications

  2024cites this paper
• Nursing Process of an Adolescence Patient with Hyperglycemia According to King's Goal Attainment Model: A Case Study

  2023cites this paper
• Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry

  2022cites this paper
• Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes

  2022cites this paper
• Recurrent moderate hypoglycemia accelerates the progression of Alzheimer’s disease through impairment of the TRPC6/GLUT3 pathway

  2022cites this paper
• Intermittently Scanned and Real-Time Continuous Glucose Monitoring for People With Diabetes

  2022cites this paper
• Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: results from the Spanish national registry.

  2022cites this paper
• Study on the changes of blood glucose in hemodialysis patients with diabetes.

  2021cites this paper
• Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition.

  2021cites this paper
• Machine Learning Techniques for Hypoglycemia Prediction: Trends and Challenges

  2021cites this paper
• Hypoglycemia Communication in Primary Care Visits for Patients with Diabetes

  2021cites this paper
• Embracing new technology to overcome severe hypoglycaemia in a patient with visual impairment

  2021cites this paper
• Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition.

  2021cites this paper
• New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions

  2021cites this paper
• Evolution in Overcoming Barriers in Management of Diabetes: Hypoglycemia

  2021cites this paper
• The competitive athlete with type 1 diabetes

  2020cites this paper
• From insulin replacement to bioengineered, encapsulated organoids

  2020cites this paper
• Glycerol Potentiates the Effects of Glucose in Promoting Glucose Recovery During Hypoglycemia: From Basic to Clinical Investigations and Their Therapeutic Application

  2020cites this paper
• Glycemic Status Assessment by the Latest Glucose Monitoring Technologies

  2020cites this paper
• Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin‐resistant hepatocytes

  2020cites this paper
• The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring

  2020cites this paper
• Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia

  2019cites this paper
• Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus

  2019cites this paper
• Monitoraggio in continuo del glucosio: il ruolo della tecnologia nella gestione del diabete mellito

  2019cites this paper
• Peur ou indifférence : psychopathologie de l’hypoglycémie

  2019cites this paper
• Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia.

  2018cites this paper
• Resumen ejecutivo: Documento de posicionamiento: evaluación y manejo de la hipoglucemia en el paciente con diabetes mellitus 2020. Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición

  year unknowncites this paper